Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery
Citations Over TimeTop 10% of 2020 papers
Abstract
The stimulator of interferon (IFN) genes (STING) pathway constitutes a highly important part of immune responses against various cancers and infections. Consequently, administration of STING agonists such as cyclic GMP-AMP (cGAMP) has been identified as a promising approach to target these diseases. In cancer cells, STING signaling is frequently impaired by epigenetic silencing of STING; hence, conventional delivery of only its agonist cGAMP may be insufficient to trigger STING signaling. In this work, while expression of STING lacking the transmembrane (TM) domain is known to be unresponsive to STING agonists and is dominant negative when coexpressed with the full-length STING inside cells, we observed that the recombinant TM-deficient STING protein complexed with cGAMP could effectively trigger STING signaling when delivered in vitro and in vivo, including in STING-deficient cell lines. Thus, this bioinspired method using TM-deficient STING may present a universally applicable platform for cGAMP delivery.
Related Papers
- → Putting the sting back in STING therapy: novel delivery vehicles for improved STING activation(2024)3 cited
- Myocardial dysfunction in children with scorpion sting envenomation.(2015)
- → An investigation of the interference effects of a sting support system on the pressure distribution over a body of revolution(1949)1 cited
- → STING structure probed(2019)
- → Investigating mechanisms of T Cell recruitment to sites of inflammation and injury(2021)